A Nice Outsourcing View
What is the current state of pharma contract development and manufacturing?
Stephanie Sutton |
According to That’s Nice, the health of the contract development and manufacturing market correlates directly with the health of the overall pharma industry – and the good news is that both sectors are fairing well. For CDMOs, however, competition in the marketplace is strong, and many sponsors (52 percent) are looking to decrease their outsourcing spend over the next five years.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine